Home LiteratureArticle Details
PMID: 10450521 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Review

Viruses, host responses, and autoimmunity.

Immunological reviews ·Vol. 169 ·1999-06-00 ·Pages 241-53

Horwitz MS, Sarvetnick N

Abstract

Conceptually, the initiation of autoimmune disease can be described as a three-stage process involving both genetic and environmental influences. This process begins with the development of an autoimmune cellular repertoire, followed by activation of these autoreactive cells in response to a localized target and, finally, the immune system's failure to regulate these self-reactive constituents. Viruses have long been associated with inciting autoimmune disorders. Two mechanisms have been proposed to explain how a viral infection can overcome immunological tolerance to self-components and initiate an organ-specific autoreactive process; these mechanisms are molecular mimicry and bystander activation. Both pathways, as discussed here, could play pivotal roles in the development of autoimmunity without necessarily excluding each other. Transgene technology has allowed us and others to examine more closely the roles of these mechanisms in mice and to dissect the requirements for initiating disease. These results demonstrate that bystander activation is the most likely explanation for disease development. Additional evidence suggests a further role for viruses in the reactivation and chronicity of autoimmune diseases. In this scenario, a second invasion by a previously infecting virus may restimulate already existing autoreactive lymphocytes, and thereby contribute to the diversity of the immune response.

MeSH Terms
Animals Autoimmunity Disease Models, Animal Humans Inflammation/immunology Lymphocyte Activation Mice Mice, Transgenic Molecular Mimicry Organ Specificity Virus Diseases/immunology Viruses/immunology,pathogenicity
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Horwitz M S
Department of Immunology, Scripps Research Institute, La Jolla, California 92037, USA.
Sarvetnick N
References (120)
120 references, click to expand
  1. HLA DRB4 0101-restricted immunodominant T cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune diseases.
    J Exp Med. 1995 May 1;181(5):1835-45 PMID: 7536796
  2. The role of viruses in the pathogenesis of pancreatic disease and diabetes mellitus.
    Prog Med Virol. 1975;19:161-214 PMID: 164049
  3. The functional significance of epitope spreading and its regulation by co-stimulatory molecules.
    Immunol Rev. 1998 Aug;164:63-72 PMID: 9795764
  4. Virus-induced immunoinflammatory lesions in the absence of viral antigen recognition.
    J Immunol. 1998 Oct 15;161(8):4289-300 PMID: 9780205
  5. Theiler's murine encephalomyelitis: a model of demyelination and persistence of virus.
    Crit Rev Immunol. 1987;7(4):325-65 PMID: 2827957
  6. An interferon-inducible molecule on brain endothelium which controls lymphocyte adhesion mediated by integrins.
    Immunology. 1995 Mar;84(3):453-60 PMID: 7751030
  7. Frequent expression of interleukin-10 by Epstein-Barr virus-harboring tumor cells of Hodgkin's disease.
    Blood. 1996 Apr 1;87(7):2918-29 PMID: 8639912
  8. Genetics of autoimmune disease.
    Curr Opin Immunol. 1995 Dec;7(6):786-92 PMID: 8679121
  9. Recruitment and proliferation of CD8+ T cells in respiratory virus infections.
    J Immunol. 1995 Jun 1;154(11):6013-21 PMID: 7751644
  10. Minimal bystander activation of CD8 T cells during the virus-induced polyclonal T cell response.
    J Exp Med. 1997 May 5;185(9):1629-39 PMID: 9151900
  11. Myelin basic protein and human coronavirus 229E cross-reactive T cells in multiple sclerosis.
    Ann Neurol. 1996 Feb;39(2):233-40 PMID: 8967755
  12. Induction of bystander T cell proliferation by viruses and type I interferon in vivo.
    Science. 1996 Jun 28;272(5270):1947-50 PMID: 8658169
  13. The basis of autoimmunity: Part II. Genetic predisposition.
    Immunol Today. 1995 Mar;16(3):150-9 PMID: 7718089
  14. Administering glutamic acid decarboxylase to NOD mice prevents diabetes.
    J Autoimmun. 1994 Dec;7(6):845-50 PMID: 7888040
  15. High frequency of cross-reactive cytotoxic T lymphocytes elicited during the virus-induced polyclonal cytotoxic T lymphocyte response.
    J Exp Med. 1993 Feb 1;177(2):317-27 PMID: 8093891
  16. Detailed in vivo analysis of interferon-gamma induced major histocompatibility complex expression in the the central nervous system: astrocytes fail to express major histocompatibility complex class I and II molecules.
    Lab Invest. 1999 Feb;79(2):235-42 PMID: 10068211
  17. Bystander activation of cytotoxic T cells: studies on the mechanism and evaluation of in vivo significance in a transgenic mouse model.
    J Exp Med. 1997 Apr 7;185(7):1241-51 PMID: 9104811
  18. Cytokine- and virus-stimulated airway smooth muscle cells produce IL-11 and other IL-6-type cytokines.
    Am J Physiol. 1997 Sep;273(3 Pt 1):L648-55 PMID: 9316501
  19. T cell cross-reactivity between coxsackievirus and glutamate decarboxylase is associated with a murine diabetes susceptibility allele.
    J Exp Med. 1994 Nov 1;180(5):1979-84 PMID: 7964474
  20. Transforming growth factor-beta 1 in chronic hepatitis C.
    J Viral Hepat. 1997 Jan;4(1):29-35 PMID: 9031062
  21. Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15.
    Immunity. 1998 May;8(5):591-9 PMID: 9620680
  22. Using transgenic mouse models to dissect the pathogenesis of virus-induced autoimmune disorders of the islets of Langerhans and the central nervous system.
    Immunol Rev. 1996 Aug;152:111-43 PMID: 8930670
  23. Viruses and the pathogenesis of diabetes mellitus.
    Diabetes. 1978 Nov;27(11):1126-40 PMID: 214368
  24. The role of viruses and environmental factors in the induction of diabetes.
    Curr Top Microbiol Immunol. 1990;164:95-123 PMID: 2073786
  25. Local expression of TNFalpha in neonatal NOD mice promotes diabetes by enhancing presentation of islet antigens.
    Immunity. 1998 Nov;9(5):733-43 PMID: 9846494
  26. A molecular model of MHC class-I-restricted antigen processing.
    Immunol Today. 1992 May;13(5):173-9 PMID: 1386516
  27. The paradoxical effects of interleukin 10 in the immunoregulation of autoimmune diabetes.
    J Autoimmun. 1996 Apr;9(2):283-6 PMID: 8738975
  28. Autoreactivity in HIV-1 infection: the role of molecular mimicry.
    Clin Immunol Immunopathol. 1995 Jun;75(3):197-205 PMID: 7768037
  29. Molecular mimicry by herpes simplex virus-type 1: autoimmune disease after viral infection.
    Science. 1998 Feb 27;279(5355):1344-7 PMID: 9478893
  30. A prospective study of the role of coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Childhood Diabetes in Finland (DiMe) Study Group.
    Diabetes. 1995 Jun;44(6):652-7 PMID: 7789630
  31. Interferon-mediated induction of class I MHC products in human neuronal cell lines: analysis of HLA and beta 2-m RNA, and HLA-A and HLA-B proteins and polymorphic specificities.
    J Interferon Res. 1986 Jun;6(3):257-65 PMID: 3091712
  32. Virus-induced diabetes mellitus.
    Arch Virol. 1977;54(1-2):1-17 PMID: 196570
  33. Cytokine release from microglia: differential inhibition by pentoxifylline and dexamethasone.
    J Infect Dis. 1992 Oct;166(4):847-53 PMID: 1527422
  34. Viral antibodies in diabetes mellitus.
    Br Med J. 1969 Sep 13;3(5671):627-30 PMID: 5811681
  35. Coxsackie viruses and diabetes mellitus.
    Br Med J. 1973 Nov 3;4(5887):260-2 PMID: 4753237
  36. Production of interleukin 10 by islet cells accelerates immune-mediated destruction of beta cells in nonobese diabetic mice.
    J Exp Med. 1994 Apr 1;179(4):1379-84 PMID: 8145050
  37. Astrocyte-specific but not neuron-specific transmembrane TNF triggers inflammation and degeneration in the central nervous system of transgenic mice.
    J Immunol. 1997 Jan 1;158(1):438-45 PMID: 8977220
  38. Sequence homology between certain viral proteins and proteins related to encephalomyelitis and neuritis.
    Science. 1985 Jul 19;229(4710):282-4 PMID: 2409602
  39. Massive expansion of antigen-specific CD8+ T cells during an acute virus infection.
    Immunity. 1998 Feb;8(2):167-75 PMID: 9491998
  40. Genes in the MHC that may affect antigen processing.
    Curr Opin Immunol. 1992 Feb;4(1):70-3 PMID: 1596370
  41. Detection of coxsackie B virus RNA sequences in whole blood samples from adult patients at the onset of type I diabetes mellitus.
    J Med Virol. 1997 Jun;52(2):121-7 PMID: 9179756
  42. Molecular mimicry: frequency of reactivity of monoclonal antiviral antibodies with normal tissues.
    J Virol. 1986 Jan;57(1):397-401 PMID: 3753614
  43. Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading.
    Nat Med. 1997 Oct;3(10):1133-6 PMID: 9334726
  44. Molecular mimicry and immune-mediated diseases.
    FASEB J. 1998 Oct;12(13):1255-65 PMID: 9761770
  45. Antibodies to glutamic acid decarboxylase and P2-C peptides in sera from coxsackie virus B4-infected mice and IDDM patients.
    Diabetes. 1994 Oct;43(10):1260-6 PMID: 7523207
  46. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein.
    Cell. 1995 Mar 10;80(5):695-705 PMID: 7534214
  47. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes.
    Nature. 1993 Nov 4;366(6450):69-72 PMID: 7694152
  48. Several different enterovirus serotypes can be associated with prediabetic autoimmune episodes and onset of overt IDDM. Childhood Diabetes in Finland (DiMe) Study Group.
    J Med Virol. 1998 Sep;56(1):74-8 PMID: 9700636
  49. Effects of interferon-gamma on primary cultures of human brain microvessel endothelial cells.
    Am J Pathol. 1993 Apr;142(4):1265-78 PMID: 8475997
  50. Evolution of the T-cell repertoire during the course of experimental immune-mediated demyelinating diseases.
    Immunol Rev. 1995 Apr;144:225-44 PMID: 7590815
  51. Epitope spreading leads to myelin-specific autoimmune responses in SJL mice chronically infected with Theiler's virus.
    J Neurovirol. 1997 May;3 Suppl 1:S62-5 PMID: 9179798
  52. Virus-induced autoimmunity through molecular mimicry.
    Ann N Y Acad Sci. 1988;540:210-7 PMID: 2462803
  53. How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a transgenic model.
    Immunity. 1994 Jun;1(3):231-42 PMID: 7889411
  54. Molecular mimicry.
    Adv Parasitol. 1994;34:81-132 PMID: 7976753
  55. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection.
    Immunity. 1998 Feb;8(2):177-87 PMID: 9491999
  56. Kinetics of cytokine expression during primary human immunodeficiency virus type 1 infection.
    Proc Natl Acad Sci U S A. 1996 Apr 30;93(9):4386-91 PMID: 8633076
  57. IL-10 impacts autoimmune diabetes via a CD8+ T cell pathway circumventing the requirement for CD4+ T and B lymphocytes.
    J Immunol. 1998 Oct 15;161(8):4420-7 PMID: 9780221
  58. Epidemiologic contributions to multiple sclerosis: an overview.
    Neurology. 1980 Jul;30(7 Pt 2):61-79 PMID: 6993993
  59. Respiratory syncytial virus G-protein modulates cytokine release from human peripheral blood mononuclear cells.
    J Leukoc Biol. 1996 Mar;59(3):403-6 PMID: 8604019
  60. Indications that maternal coxsackie B virus infection during pregnancy is a risk factor for childhood-onset IDDM.
    Diabetologia. 1995 Nov;38(11):1371-3 PMID: 8582549
  61. Focal expression of interleukin-2 does not break unresponsiveness to "self" (viral) antigen expressed in beta cells but enhances development of autoimmune disease (diabetes) after initiation of an anti-self immune response.
    J Clin Invest. 1995 Feb;95(2):477-85 PMID: 7860729
  62. The epidemiology of insulin dependent diabetes with particular reference to the relationship of virus infection to its etiology.
    Epidemiol Rev. 1980;2:49-70 PMID: 7000538
  63. Viruses and T cell turnover: evidence for bystander proliferation.
    Immunol Rev. 1996 Apr;150:129-42 PMID: 8782705
  64. Anti-GM1 IgG antibodies and Campylobacter bacteria in Guillain-Barré syndrome: evidence of molecular mimicry.
    Ann Neurol. 1995 Aug;38(2):170-5 PMID: 7654064
  65. Insulin-dependent diabetes mellitus induced in transgenic mice by ectopic expression of class II MHC and interferon-gamma.
    Cell. 1988 Mar 11;52(5):773-82 PMID: 2449974
  66. Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity.
    Cell. 1993 Feb 26;72(4):551-60 PMID: 7679952
  67. Clinical and experimental aspects of viral myocarditis.
    Clin Microbiol Rev. 1989 Apr;2(2):191-203 PMID: 2650861
  68. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis.
    J Exp Med. 1995 Jul 1;182(1):75-85 PMID: 7540658
  69. Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay.
    Diabetes. 1994 Mar;43(3):459-67 PMID: 8314020
  70. Molecular mimicry and autoimmune disease.
    Cell. 1987 Sep 11;50(6):819-20 PMID: 3621346
  71. Enterovirus infections and insulin dependent diabetes mellitus--evidence for causality.
    Clin Diagn Virol. 1998 Apr;9(2-3):77-84 PMID: 9645988
  72. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice.
    Nature. 1993 Nov 4;366(6450):72-5 PMID: 8232539
  73. IL-10 is necessary and sufficient for autoimmune diabetes in conjunction with NOD MHC homozygosity.
    J Exp Med. 1996 Jun 1;183(6):2663-8 PMID: 8676087
  74. Tissue-specific expression of interleukin-4 induces extracellular matrix accumulation and extravasation of B cells.
    Lab Invest. 1997 Jan;76(1):117-28 PMID: 9010455
  75. Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry.
    Nat Med. 1998 Jul;4(7):781-5 PMID: 9662368
  76. Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response.
    Cell. 1991 Apr 19;65(2):319-31 PMID: 1901765
  77. Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes.
    J Clin Invest. 1994 Nov;94(5):2125-9 PMID: 7962558
  78. Immunity and immunopathology in dengue virus infections.
    Semin Immunol. 1992 Apr;4(2):121-7 PMID: 1617166
  79. A role for transforming growth factor-beta1 in the increased pneumonitis in murine allogeneic bone marrow transplant recipients with graft-versus-host disease after pulmonary herpes simplex virus type 1 infection.
    Blood. 1998 Oct 1;92(7):2581-9 PMID: 9746800
  80. Oligodendrocyte-specific expression and autoantigenicity of transaldolase in multiple sclerosis.
    J Exp Med. 1994 Nov 1;180(5):1649-63 PMID: 7964452
  81. Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice.
    Cell. 1991 Apr 19;65(2):305-17 PMID: 1901764
  82. Interferon-gamma: mechanism of action and therapeutic potential.
    Biochem Pharmacol. 1990 Oct 1;40(7):1433-9 PMID: 2121146
  83. A case-control study of group B Coxsackievirus immunoglobulin M antibody prevalence and HLA-DR antigens in newly diagnosed cases of insulin-dependent diabetes mellitus.
    Am J Epidemiol. 1992 Jun 15;135(12):1331-8 PMID: 1324601
  84. Interleukin 10, a novel B cell stimulatory factor: unresponsiveness of X chromosome-linked immunodeficiency B cells.
    J Exp Med. 1990 Dec 1;172(6):1625-31 PMID: 2124252
  85. Binding of the Epstein-Barr virus to human platelets causes the release of transforming growth factor-beta.
    J Immunol. 1997 Oct 15;159(8):3984-8 PMID: 9378987
  86. Molecular mimicry and ankylosing spondylitis: possible role of a novel sequence in pullulanase of Klebsiella pneumoniae.
    FEBS Lett. 1995 Aug 7;369(2-3):243-8 PMID: 7649265
  87. Loss of pancreatic islet tolerance induced by beta-cell expression of interferon-gamma.
    Nature. 1990 Aug 30;346(6287):844-7 PMID: 2118234
  88. Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus.
    J Clin Invest. 1992 Jan;89(1):283-92 PMID: 1370298
  89. Absence of neurological deficits following extensive demyelination in a class I-deficient murine model of multiple sclerosis.
    Nat Med. 1998 Feb;4(2):187-193 PMID: 9461192
  90. Secondary immune amplification following live poliovirus immunization in humans.
    Clin Immunol Immunopathol. 1987 Sep;44(3):321-8 PMID: 3040309
  91. Cytokines up-regulate Ia expression in organotypic cultures of central nervous system tissue.
    J Neuroimmunol. 1989 Oct;24(3):239-48 PMID: 2808691
  92. Differential expression of inflammatory cytokines parallels progression of central nervous system pathology in two clinically distinct models of multiple sclerosis.
    J Immunol. 1998 Oct 15;161(8):4437-46 PMID: 9780223
  93. Diabetes mellitus and autoimmunity in patients with the congenital rubella syndrome.
    Rev Infect Dis. 1985 Mar-Apr;7 Suppl 1:S170-6 PMID: 3890104
  94. Primary demyelination in transgenic mice expressing interferon-gamma.
    Nat Med. 1997 Sep;3(9):1037-1041 PMID: 9288735
  95. Coxsackievirus B-3 myocarditis. Acute and chronic forms of the disease caused by different immunopathogenic mechanisms.
    Am J Pathol. 1987 Sep;128(3):455-63 PMID: 2957924
  96. Geographic differences in the risk of insulin-dependent diabetes mellitus: the importance of registries.
    Diabetes Care. 1985 Sep-Oct;8 Suppl 1:101-7 PMID: 4053948
  97. Myasthenia gravis-like syndrome induced by expression of interferon gamma in the neuromuscular junction.
    J Exp Med. 1995 Feb 1;181(2):547-57 PMID: 7836911
  98. Polygenic control of autoimmune diabetes in nonobese diabetic mice.
    Nat Genet. 1993 Aug;4(4):404-9 PMID: 8401590
  99. Antigenic mimicry between measles virus and human T lymphocytes.
    J Infect Dis. 1987 Sep;156(3):526-7 PMID: 3497211
  100. Enteroviruses and myocarditis: viral pathogenesis through replication, cytokine induction, and immunopathogenicity.
    Adv Virus Res. 1998;51:35-80 PMID: 9891585
  101. Responses of NOD congenic mice to a glutamic acid decarboxylase-derived peptide.
    J Autoimmun. 1994 Oct;7(5):635-41 PMID: 7840855
  102. Interferon-gamma in progression to chronic demyelination and neurological deficit following acute EAE.
    Mol Cell Neurosci. 1998 Dec;12(6):376-89 PMID: 9888990
  103. Clinical viral infections and multiple sclerosis.
    Lancet. 1985 Jun 8;1(8441):1313-5 PMID: 2860501
  104. Apoptosis defects analyzed in TcR transgenic and fas transgenic lpr mice.
    Int Rev Immunol. 1994;11(4):321-42 PMID: 7528763
  105. Responses to influenza vaccination in different T-cell subsets: a comparison of healthy young and older adults.
    Vaccine. 1998 Nov;16(18):1742-7 PMID: 9778750
  106. Triggers of autoimmune disease in a murine TCR-transgenic model for multiple sclerosis.
    J Immunol. 1997 Jul 1;159(1):497-507 PMID: 9200491
  107. Accumulation of extracellular matrix and developmental dysregulation in the pancreas by transgenic production of transforming growth factor-beta 1.
    Am J Pathol. 1995 Jul;147(1):42-52 PMID: 7604884
  108. Inducers of interferon and host resistance. II. Multistranded synthetic polynucleotide complexes.
    Proc Natl Acad Sci U S A. 1967 Sep;58(3):1004-10 PMID: 5233831
  109. Viral infections trigger multiple sclerosis relapses: a prospective seroepidemiological study.
    J Neurol. 1993 Jul;240(7):417-22 PMID: 8410082
  110. Viral infection of transgenic mice expressing a viral protein in oligodendrocytes leads to chronic central nervous system autoimmune disease.
    J Exp Med. 1996 Dec 1;184(6):2371-84 PMID: 8976191
  111. Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses.
    J Exp Med. 1994 Jun 1;179(6):1933-43 PMID: 8195718
  112. Sensitization to self (virus) antigen by in situ expression of murine interferon-gamma.
    J Clin Invest. 1995 Feb;95(2):486-92 PMID: 7860730
  113. Regulatory T cells in the control of autoimmunity: the essential role of transforming growth factor beta and interleukin 4 in the prevention of autoimmune thyroiditis in rats by peripheral CD4(+)CD45RC- cells and CD4(+)CD8(-) thymocytes.
    J Exp Med. 1999 Jan 18;189(2):279-88 PMID: 9892610
  114. Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity.
    Science. 1985 Nov 29;230(4729):1043-5 PMID: 2414848
  115. Experimental models of virus-induced demyelination of the central nervous system.
    Ann Neurol. 1982 Feb;11(2):109-27 PMID: 6280582
  116. TGF-beta1 alters APC preference, polarizing islet antigen responses toward a Th2 phenotype.
    Immunity. 1998 May;8(5):601-13 PMID: 9620681
  117. Local production of human IL-6 promotes insulitis but retards the onset of insulin-dependent diabetes mellitus in non-obese diabetic mice.
    Int Immunol. 1994 Dec;6(12):1829-37 PMID: 7696203
  118. Activated microglia mediate neuronal cell injury via a nitric oxide mechanism.
    J Immunol. 1992 Oct 15;149(8):2736-41 PMID: 1383325
  119. Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice.
    J Exp Med. 1996 Sep 1;184(3):1093-9 PMID: 9064326
  120. Cross-reactivity between streptococcus and human tissue: a model of molecular mimicry and autoimmunity.
    Curr Top Microbiol Immunol. 1989;145:5-26 PMID: 2680297
Article Info
Journal
Immunological reviews
Abbr.
Immunol Rev
ISSN
0105-2896
Published
1999-06-00
Pages
241-53
Language
English
Region
England
NLM ID
7702118
PMCID
PMC7165657
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]